We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$25.3B
AUM Growth
+$5.49B
Cap. Flow
+$2.44B
Cap. Flow %
9.65%
Top 10 Hldgs %
19.18%
Holding
3,786
New
851
Increased
1,117
Reduced
1,039
Closed
652

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$142M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$94.7M
3
WDAY icon
Workday
WDAY
+$80M
4
SHW icon
Sherwin-Williams
SHW
+$72.3M
5
MMM icon
3M
MMM
+$60.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.27%
2 Technology 10.11%
3 Healthcare 6.67%
4 Financials 6.57%
5 Industrials 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
3051
Geron
GERN
$911M
$52.3K ﹤0.01%
21,612
-36,989
-63% -$82.9K
OMIC
3052
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$52.1K ﹤0.01%
+864
New +$57.9K
LXRX icon
3053
Lexicon Pharmaceuticals
LXRX
$1.02B
$52.1K ﹤0.01%
+27,264
New +$58K
SFIX
3054
Stitch Fix
SFIX
$478M
$50.6K ﹤0.01%
+16,264
New +$60.8K
INSG icon
3055
Inseego
INSG
$108M
$49.9K ﹤0.01%
5,928
+4,660
+368% +$70K
RBOT
3056
DELISTED
Vicarious Surgical
RBOT
$49.7K ﹤0.01%
+819
New +$76.1K
KRON
3057
DELISTED
Kronos Bio
KRON
$49K ﹤0.01%
+30,218
New +$69.6K
AXTI icon
3058
AXT Inc
AXTI
$3.09B
$48.6K ﹤0.01%
+11,104
New +$54.1K
NNDM
3059
Nano Dimension
NNDM
$309M
$48.5K ﹤0.01%
21,085
-21,689
-51% -$52.8K
ORGO icon
3060
Organogenesis Holdings
ORGO
$308M
$48.3K ﹤0.01%
17,968
-38,824
-68% -$113K
NUVB icon
3061
Nuvation Bio
NUVB
$2.24B
$47K ﹤0.01%
24,472
-48,774
-67% -$98.7K
AIRS icon
3062
AirSculpt Technologies
AIRS
$325M
$46.9K ﹤0.01%
+12,666
New +$58.8K
EVLV icon
3063
Evolv Technologies
EVLV
$943M
$46.5K ﹤0.01%
+17,958
New +$52.9K
NUTX
3064
Nutex Health
NUTX
$1B
$46.3K ﹤0.01%
+162
New +$31.1K
AHT
3065
Ashford Hospitality Trust
AHT
$21M
$46K ﹤0.01%
1,030
-4,882
-83% -$315K
AMRX icon
3066
Amneal Pharmaceuticals
AMRX
$5.72B
$45.9K ﹤0.01%
+23,057
New +$51.7K
MMAT
3067
DELISTED
Meta Materials Inc. Common Stock
MMAT
$45.7K ﹤0.01%
384
-2,077
-84% -$275K
RAD
3068
DELISTED
Rite Aid Corporation
RAD
$45.3K ﹤0.01%
+13,569
New +$64.5K
BHR
3069
Braemar Hotels & Resorts
BHR
$153M
$42.8K ﹤0.01%
10,418
-80
-0.8% -$328
RIGL icon
3070
Rigel Pharmaceuticals
RIGL
$680M
$42K ﹤0.01%
2,801
-53,881
-95% -$494K
LILM
3071
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$40.4K ﹤0.01%
35,471
-1,106
-3% -$1.75K
SCWO icon
3072
374Water
SCWO
$37.8M
$40K ﹤0.01%
+1,367
New +$43.4K
JNCE
3073
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$39.5K ﹤0.01%
+35,606
New +$50.7K
ONDS icon
3074
Ondas Inc
ONDS
$4.44B
$39.2K ﹤0.01%
+24,683
New +$72.5K
HUT
3075
Hut 8
HUT
$12.4B
$39.1K ﹤0.01%
9,205
+4,543
+97% +$34.2K

Similar funds

Squarepoint's Q4 2022 Portfolio in Review

As of Q4 2022, Squarepoint held 3,786 positions worth $25.3B, up 28% from $19.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Squarepoint deployed $2.44B of net new capital in Q4 2022, opening 851 new positions and adding to 1,117 existing holdings. Its largest new stake was Walmart Inc: 3,657,033 shares worth $173M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Comcast, an estimated $142M trimmed.

  • Squarepoint's largest Q4 2022 buy was Walmart Inc: 3,657,033 shares worth $173M.
  • Squarepoint added most to Apple in Q4 2022, an estimated $252M increase.
  • Squarepoint's biggest Q4 2022 reduction was Comcast, cutting an estimated $142M.
  • Squarepoint fully exited iShares Russell 2000 ETF in Q4 2022, selling an estimated $59.4M.
  • Squarepoint's ten largest holdings make up 19% of its $25.3B portfolio in Q4 2022.
  • Squarepoint opened 851 new positions and closed 652 in Q4 2022.
  • Squarepoint's portfolio value rose 28% quarter-over-quarter to $25.3B.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.